Shortage compounding is not a loophole, Scott explains to Axios

In one of the many stories about compounded GLP-1s and the battle with pharma companies, Scott makes it clear to Axios that “It is absolutely intentional policy on the part of FDA.”

Wired wrote about “The Crackdown on Compounded GLP-1 Meds,” where it made clear that it doesn’t...

Getting away from GLP-1s, Pharmaceutical Executive features CEO Scott Brunner and Chief Advocacy...

NPR station WHYY was one of many that covered the Hims & Hers Super Bowl ad, and one of many that...

Shortage compounding is not a loophole, Scott explains to Axios

Related posts

Wired story isn’t perfect, but…

PharmExec features APC execs talking about the compounding process

Live on WHYY